AJP - Endocrinology and Metabolism, Vol 267, Issue 4 E566-E572, Copyright © 1994 by American Physiological Society

ARTICLES

VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin

G. F. Lewis, B. Zinman, K. D. Uffelman, L. Szeto, B. Weller and G. Steiner
Department of Medicine, University of Toronto, Ontario, Canada.

Acute changes in very low-density lipoprotein (VLDL) triglyceride (TG) and VLDL apolipoprotein (apo) B production were examined in 11 healthy young males in response to insulin delivered either by the peripheral venous route or secreted directly by the pancreas. Steady rates of pancreatic insulin secretion were achieved for 5 h by a programmed intravenous tolbutamide infusion, while euglycemia was maintained with a dextrose infusion. Insulin secretory rate was calculated from peripheral C-peptide levels by deconvolution, and, in a subsequent study, exogenous insulin was infused peripherally to match this pancreatic insulin secretory rate in each subject. Changes in VLDL TG and VLDL apo B production were determined semiquantitatively on each occasion by examining the change in slope of the specific activity (SA) of 3H-labeled triglyceride glycerol ([3H]TGG) and 131I-VLDL apo B vs. time curves, respectively, occurring with acute hyperinsulinemia. Plasma-free fatty acids (FFA), TG, apo B, and VLDL TG/VLDL apo B ratio decreased to a similar extent in both studies after the onset of hyperinsulinemia. VLDL TG production decreased significantly in both the tolbutamide (-47.1 +/- 7.3%, P < 0.002) and the exogenous insulin infusion study (-52.8 +/- 12.4%, P < 0.005). VLDL apo B production also decreased significantly in both studies (-58.9 +/- 7.5%, P = 0.0007 and -52.1 +/- 6.8%, P < 0.006, respectively), and there were no significant differences between studies. Tolbutamide was shown to have no independent effect on VLDL TG or VLDL apo B production in four insulin-deficient diabetic subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				B. Mittendorfer, B. W. Patterson, S. Klein, and L. S. Sidossis VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E708 - E715. [Abstract] [Full Text] [PDF]

				A.-M. Brown and G. F. Gibbons Insulin Inhibits the Maturation Phase of VLDL Assembly via a Phosphoinositide 3-Kinase--Mediated Event Arterioscler. Thromb. Vasc. Biol., October 1, 2001; 21(10): 1656 - 1661. [Abstract] [Full Text] [PDF]

				B. Mittendorfer and L. S Sidossis Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets Am. J. Clinical Nutrition, May 1, 2001; 73(5): 892 - 899. [Abstract] [Full Text] [PDF]

				D. V. Chirieac, L. R. Chirieac, J. P. Corsetti, J. Cianci, C. E. Sparks, and J. D. Sparks Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1003 - E1011. [Abstract] [Full Text] [PDF]

				G. F. Lewis, M. Vranic, and A. Giacca Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E177 - E186. [Abstract] [Full Text] [PDF]

				R. Malmstrom, C. J. Packard, T. D. G. Watson, S. Rannikko, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M.-R. Taskinen Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1454 - 1464. [Abstract] [Full Text]